Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.
METHODS FOR CLUSTERING TIME SERIES DATA ACQUIRED FROM MOBILE HEALTH APPS.
Transfer Learning From Convolutional Neural Networks for Computer-Aided Diagnosis: A Comparison of Digital Breast Tomosynthesis and Full-Field Digital Mammography.
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.
See All 30 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.
Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma. Leukemia. 2019 09; 33(9):2127-2143.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Humans
Immunologic Factors
Multiple Myeloma
Oligopeptides
Proteasome Inhibitors
authors with profiles
Andrzej Jakubowiak